Theravance Biopharma (TBPH) Tops Q2 EPS by 52c, Revenues Beat

July 31, 2019 7:20 AM

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($0.72), $0.52 better than the analyst estimate of ($1.24). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found